Sensei Biotherapeutics Inc (NASDAQ:SNSE) — Market Cap & Net Worth
Market Cap & Net Worth: Sensei Biotherapeutics Inc (SNSE)
Sensei Biotherapeutics Inc (NASDAQ:SNSE) has a market capitalization of $18.59 Million ($18.59 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25437 globally and #5371 in its home market, demonstrating a 78.66% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sensei Biotherapeutics Inc's stock price $25.96 by its total outstanding shares 1341941 (1.34 Million). Also see how large is Sensei Biotherapeutics Inc's balance sheet for a full breakdown of the balance sheet.
Sensei Biotherapeutics Inc Market Cap History: 2021 to 2026
Sensei Biotherapeutics Inc's market capitalization history from 2021 to 2026. Data shows growth from $7.78 Million to $34.84 Million (6.00% CAGR). Also see cash flow conversion of Sensei Biotherapeutics Inc for how efficiently the company converts equity into cash flow.
Index Memberships
Sensei Biotherapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #720 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #2352 of 3165 |
Weight: Sensei Biotherapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sensei Biotherapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sensei Biotherapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Sensei Biotherapeutics Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SNSE by Market Capitalization
Companies near Sensei Biotherapeutics Inc in the global market cap rankings as of September 18, 2026. Review SNSE goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Sensei Biotherapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
Sensei Biotherapeutics Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Sensei Biotherapeutics Inc's market cap moved from $7.78 Million to $ 34.84 Million, with a yearly change of 6.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $34.84 Million | +143.30% |
| 2025 | $14.32 Million | +2077.11% |
| 2024 | $657.69K | -29.18% |
| 2023 | $928.62K | -53.56% |
| 2022 | $2.00 Million | -74.31% |
| 2021 | $7.78 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Sensei Biotherapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.59 Million USD |
| MoneyControl | $18.59 Million USD |
| MarketWatch | $18.59 Million USD |
| marketcap.company | $18.59 Million USD |
| Reuters | $18.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune … Read more